How Advanced Therapies are Changing the Landscape of Rare Disease, New Webinar Hosted by Xtalks
TORONTO (PRWEB) February 11, 2019 -- New developments in advanced therapy medicine products (ATMPs) comprising cell and gene therapy products show the potential to modify or even cure severe chronic conditions for which previously no treatment existed. As a consequence, the dynamic market for innovative therapies such as CAR-T, immuno-oncology, and gene and cell-based therapies grows across the globe. Academic institutes and biotech companies are contributing to these developments both in terms of scientific discovery and undertaking clinical trials aiming for regulatory approvals to treat specific patient populations. While we might be in a golden age of medicine due to advancements in ATMPs, innovative clinical research and development remain crucial for getting treatments to patients.
Join experts from Medpace – Marco Tangelder, MD, PhD, Senior Medical Director, Todd Banks, PharmD, RPh. Director of Regulatory Affairs and Regulatory Intelligence and Madhavi Malladi, PhD, Clinical Trial Manager in a live session on Thursday, February 28, 2019 at 11am EST (4pm GMT) to explore:
• Scientific Advancements: The new and exciting landscape for advanced therapies in rare disease for a variety of indications, with a deeper dive into hematology and ophthalmology
• Regulatory Landscape: Key characteristics and considerations for obtaining orphan drug development (ODD) designation in the US as well as an overview of the comparative differences among current global orphan product laws and regulations
• Operational Considerations: Lessons-learned and best practices for operationalizing rare disease clinical trials including identifying, enrolling and retaining patients, as well as special considerations for ATMPs
For more information or to register for this event, visit How Advanced Therapies are Changing the Landscape of Rare Disease.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/
Candice Tang, Xtalks, https://www.medpace.com/, 4169776555, [email protected]
Share this article